The need for better evidence to evaluate the health & economic benefits of India′s Rashtriya Swasthya Bima Yojana
| Autor: | Arindam Nandi, E Phoebe Holtzman, Ramanan Laxminarayan, Anup Malani |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
medicine.medical_specialty
Cost-Benefit Analysis media_common.quotation_subject Impact evaluation impact evaluation India Developing country Context (language use) Review Article Financial risk protection General Biochemistry Genetics and Molecular Biology medicine Humans RSBY Quality (business) social health insurance Developing Countries Health policy media_common Insurance Health Health economics Cost–benefit analysis Public economics business.industry Health Policy Public health Environmental resource management General Medicine Public Health business |
| Zdroj: | The Indian Journal of Medical Research |
| ISSN: | 0971-5916 |
| DOI: | 10.4103/0971-5916.169194 |
| Popis: | In this review the existing evidence on the impact of Rashtriya Swasthya Bima Yojana (RSBY) is discussed in the context of international literature available on health insurance. We describe potential pathways through which health insurance can affect health and economic outcomes, discuss evidence from other developing countries, and identify potential biases and inconsistencies in existing studies on RSBY impact. Given the relatively recent introduction of RSBY, lack of quality, verifiable data on utilization patterns, and the absence of reliable evaluation studies, there is a need to exercise caution while assessing the merits of the programme. Considering the enormous potential and cost of the programme, we emphasize the need for a rigorous impact evaluation of RSBY. It will not only help capture the real impact of the scheme, but may also be able to estimate the extent of systemic inefficiencies at the level of the consumer. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|